Monkey

Hazard statements (CLP)

H302, H319, H361d, H400, H410

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Hazard statements

see section 16 : H302 - Harmful if swallowed. H319 - Causes serious eye irritation. H361d - Suspected of damaging the unborn child. H410 - Very toxic to aquatic life with long lasting effects.

Adverse physicochemical, human health and environmental effects

Harmful if swallowed. Causes serious eye irritation. Suspected of damaging the unborn child. Very toxic to aquatic life with long lasting effects.

2.2 Label elements

Labelling

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Warning Printing date: 25/08/2022 GB - en 1/13

Contains

Tebuconazole; Prochloraz; Propanoic acid, 2-hydroxy-2-ethylhexyl ester

Precautionary statements

P102 - Keep out of reach of children. P201 - Obtain special instructions before use. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective gloves, protective clothing, face protection, eye protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH401 - To avoid risks to human health and the environment, comply with the instructions for use. EUH208 - Contains Propanoic acid, 2-hydroxy-, 2-ethylhexyl ester, (2S)-. May produce an allergic reaction.

Additional information

SP 1 - Do not contaminate water with the product or its container (Do not clean application equipment near surface water/Avoid contamination via drains from farmyards and roads).

2.3 Other hazards

This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %.